| 1 (33) | Samsung Corp * | MUL |  |
| 2 (92) | F Hoffmann-La Roche * | MUL | |
| 3 (137) | AstraZeneca * | MUL | |
| 4 (153) | Bristol-Myers Squibb Company * | MUL | |
| 5 (176) | Sumitomo Group * | MUL | |
| 6 (205) | Pfizer * | MUL | |
| 7 (210) | Merck & Co Inc * | MUL | |
| 8 (215) | Novartis * | MUL | |
| 9 (220) | GlaxoSmithKline * | MUL | |
| 10 (239) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 11 (254) | Sanofi * | MUL | |
| 12 (256) | Boehringer Ingelheim * | MUL | |
| 13 (264) | Amgen * | MUL | |
| 14 (266) | Grupo Hospitalario Quironsalud * | MUL |  |
| 15 (276) | Eli Lilly * | MUL | |
| 16 (279) | Johnson & Johnson * | MUL | |
| 17 (285) | Merck KGaA * | MUL | |
| 18 (315) | Janssen | MUL | |
| 19 (321) | AbbVie * | MUL | |
| 20 (358) | Bayer * | MUL | |
| 21 (368) | Gilead Sciences * | MUL | |
| 22 (431) | Robert Bosch * | MUL | |
| 23 (476) | Koninklijke Philips NV * | MUL | |
| 24 (486) | Junta de Andalucia * | MUL |  |
| 25 (550) | Astellas Pharma Inc * | MUL | |
| 26 (559) | Ministerio de Ciencia e Innovacion * | MUL | |
| 27 (652) | HM Hospitales * | MUL | |
| 28 (746) | Hitachi * | MUL | |
| 29 (777) | Novo Nordisk * | MUL | |
| 30 (788) | Takeda Pharmaceuticals International Inc * | MUL | |
| 31 (833) | Siemens * | MUL | |
| 32 (893) | Cancer Council * | MUL |  |
| 33 (939) | General Electric Company * | MUL | |
| 34 (998) | Konica Minolta Inc * | MUL | |
| 35 (1013) | Pasteur Network * | MUL | |
| 36 (1018) | Eusko Jaurlaritza * | MUL | |
| 37 (1090) | World Health Organization * | MUL | |
| 38 (1134) | International Centre for Genetic Engineering and Biotechnology * | MUL | |
| 39 (1328) | IQVIA Inc * | MUL | |
| 40 (1436) | GE Healthcare | MUL | |
| 41 (1449) | Generalitat Valenciana * | MUL | |
| 42 (1479) | Institut de Recherche pour le Developpement * | MUL | |
| 43 (1567) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 44 (1997) | Manipal Global Education Group * | MUL | |
| 45 (2106) | GenesisCare * | MUL | |
| 46 (2494) | RTI Health Solutions * | MUL | |
| 47 (2533) | IVIRMA Global * | MUL | |
|
